197 related articles for article (PubMed ID: 11143762)
1. The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis.
Ginsberg HN; Huang LS
J Cardiovasc Risk; 2000 Oct; 7(5):325-31. PubMed ID: 11143762
[TBL] [Abstract][Full Text] [Related]
2. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
3. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
Borggreve SE; De Vries R; Dullaart RP
Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
[TBL] [Abstract][Full Text] [Related]
4. Role of lipases, lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in abnormal high density lipoprotein metabolism in insulin resistance and type 2 diabetes mellitus.
de Vries R; Borggreve SE; Dullaart RP
Clin Lab; 2003; 49(11-12):601-13. PubMed ID: 14651331
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
Kwiterovich PO
Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
[TBL] [Abstract][Full Text] [Related]
6. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
7. A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
Malloy MJ; Kane JP
Adv Intern Med; 2001; 47():111-36. PubMed ID: 11795072
[TBL] [Abstract][Full Text] [Related]
8. Regulation of plasma triglycerides in insulin resistance and diabetes.
Ginsberg HN; Zhang YL; Hernandez-Ono A
Arch Med Res; 2005; 36(3):232-40. PubMed ID: 15925013
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance.
Haffner SM
Am J Cardiol; 2002 Oct; 90(8A):55i-61i. PubMed ID: 12419481
[TBL] [Abstract][Full Text] [Related]
10. Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.
Quispe R; Martin SS; Jones SR
Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):150-6. PubMed ID: 26863278
[TBL] [Abstract][Full Text] [Related]
11. Preventing, stopping, or reversing coronary artery disease--triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: the need for recognition and treatment.
Ferguson EE
Dis Mon; 2000 Jul; 46(7):421-503. PubMed ID: 10943222
[TBL] [Abstract][Full Text] [Related]
12. Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype.
Båvenholm P; Karpe F; Proudler A; Tornvall P; Crook D; Hamsten A
Metabolism; 1995 Nov; 44(11):1481-8. PubMed ID: 7476338
[TBL] [Abstract][Full Text] [Related]
13. [Disorders of lipid metabolism in insulin resistance].
Müller-Wieland D; Krone W
Herz; 1995 Feb; 20(1):33-46. PubMed ID: 7713475
[TBL] [Abstract][Full Text] [Related]
14. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
15. Postprandial triglyceride-rich lipoprotein metabolism and insulin sensitivity in nonalcoholic steatohepatitis patients.
Cassader M; Gambino R; Musso G; Depetris N; Mecca F; Cavallo-Perin P; Pacini G; Rizzetto M; Pagano G
Lipids; 2001 Oct; 36(10):1117-24. PubMed ID: 11768156
[TBL] [Abstract][Full Text] [Related]
16. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
Tani S; Matsumoto M; Nagao K; Hirayama A
J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
[TBL] [Abstract][Full Text] [Related]
17. The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in Diabetes.
Stahel P; Xiao C; Hegele RA; Lewis GF
Can J Cardiol; 2018 May; 34(5):595-604. PubMed ID: 29459241
[TBL] [Abstract][Full Text] [Related]
18. [Disturbances of lipoprotein metabolism in metabolic syndrome].
Czyzewska M; Wolska A; Cwiklińska A; Kortas-Stempak B; Wróblewska M
Postepy Hig Med Dosw (Online); 2010 Jan; 64():1-10. PubMed ID: 20093718
[TBL] [Abstract][Full Text] [Related]
19. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
Grundy SM
Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis in type 2 diabetes mellitus: the role of insulin resistance.
Watson KE; Peters Harmel AL; Matson G
J Cardiovasc Pharmacol Ther; 2003 Dec; 8(4):253-60. PubMed ID: 14740074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
